Organization

Duke University

113 clinical trials

Clinical trial
Neurobehavioral Mechanisms Linking Childhood Adversity to Increased Risk for Smoking
Status: Recruiting, Estimated PCD: 2027-03-31
Clinical trial
Directed Topical Drug Delivery for Treatment for PASC Hyposmia
Status: Recruiting, Estimated PCD: 2024-09-01
Clinical trial
Hydroxychloroquine and Cognitive Function After Surgery
Status: Active (not recruiting), Estimated PCD: 2023-05-22
Clinical trial
The Role of Nicotine and Non-Nicotine Alkaloids in E-Cigarette Use and Dependence
Status: Completed, Estimated PCD: 2022-01-13
Clinical trial
Janus Kinase-STAT Inhibition to Reduce APOL1 Associated Kidney Disease
Status: Recruiting, Estimated PCD: 2026-03-31
Clinical trial
Comparing Two Behavioral Approaches to Quitting Smoking in Mental Health Settings
Status: Recruiting, Estimated PCD: 2025-04-01
Clinical trial
Optimizing Outpatient Anesthesia (OSPREy-Outpatient Surgery Pain Relief Enhancement)
Status: Completed, Estimated PCD: 2023-07-30
Clinical trial
Using Xenon MRI to Evaluate the Efficacy of Therapies for Idiopathic Pulmonary Fibrosis
Status: Active (not recruiting), Estimated PCD: 2024-08-30
Clinical trial
A Phase I Study of hEGFRvIII-CD3 Bi-scFv (BRiTE) in Patients With WHO Grade IV Malignant Glioma
Status: Not yet recruiting, Estimated PCD: 2026-12-01
Clinical trial
Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs
Status: Recruiting, Estimated PCD: 2024-05-01
Clinical trial
Vestibulodynia: Understanding Pathophysiology and Determining Appropriate Treatments
Status: Completed, Estimated PCD: 2024-03-13
Clinical trial
Pharmacokinetics of Drugs Administered to Children Per Standard of Care
Status: Recruiting, Estimated PCD: 2033-08-14
Clinical trial
Clinically Integrated Opportunistic PK/PD Trial in Critically Ill Children
Status: Recruiting, Estimated PCD: 2024-09-30
Clinical trial
XENON ILD: 129Xe MRI to Evaluate aNtifibrotic respOnse and progressioN in ILD
Status: Recruiting, Estimated PCD: 2026-06-01
Clinical trial
A Feasibility Study Utilizing Immune Recall to Increase Response to Checkpoint Therapy
Status: Recruiting, Estimated PCD: 2024-09-01
Clinical trial
Project HOPES: Healthy Options for Pain and Ending Smoking. A Program for Cancer Survivors.
Status: Not yet recruiting, Estimated PCD: 2025-03-09
Clinical trial
Adenosine Contrast CorrELations in Evaluating RevAscularizaTION
Status: Completed, Estimated PCD: 2022-05-04
Clinical trial
Pharmacokinetics and Pharmacodynamics of Biologic Drugs in Obese Patients With Arthritis
Status: Not yet recruiting, Estimated PCD: 2025-02-28
Clinical trial
Applied Physiology of Oxygen Toxicity: Mechanisms in Humans
Status: Recruiting, Estimated PCD: 2026-03-01
Clinical trial
CardioRenal Effects of SGLT2 Inhibition in Kidney Transplant Recipients
Status: Recruiting, Estimated PCD: 2026-07-31
Clinical trial
Protecting With ARNI Against Cardiac Consequences of Coronavirus Disease 2019
Status: Completed, Estimated PCD: 2023-06-13
Clinical trial
Splanchnic Nerve Block for Therapy of Chronic Heart Failure (Splanchnic III)
Status: Completed, Estimated PCD: 2021-06-16
Clinical trial
Hyperbaric Oxygen Therapy to Prevent Complications After Lower Limb Amputation
Status: Recruiting, Estimated PCD: 2024-12-31
Clinical trial
Fecal Microbiota Transplantation in Refractory Clostridium Difficile Colitis
Status: Recruiting, Estimated PCD: 2026-05-01
Clinical trial
Pilot Treatment of Persistent Non-Severe Postpartum Hypertension
Status: Terminated, Estimated PCD: 2021-02-12
Clinical trial
Preventing an Incurable Disease: The Prevention of Progression to Pancreatic Cancer Trial (The 3P-C Trial)
Status: Active (not recruiting), Estimated PCD: 2026-04-30
Clinical trial
Markers of Alzheimers Disease and Cognitive Outcomes After Perioperative Care
Status: Completed, Estimated PCD: 2019-01-10
Clinical trial
Mechanisms of Disease Relapse/Resistance in CAR T Therapy for Hematologic Malignancies
Status: Recruiting, Estimated PCD: 2025-11-01